Fouad Namouni is President at Blueprint Medicines Corp (BPMC). They have made 8 open-market trades across 1 company since 2021, most recently 2025-07-17.
CIK 0001815851
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPMC | SELL | 2025-03-05 | 2025-03-07 | $88.80 | $1.2M | +5.7% | -6.3% | +49.4% |
| BPMC | SELL | 2024-10-03 | 2024-10-04 | $89.32 | $649K | +0.7% | +3.5% | -1.7% |
| BPMC | SELL | 2024-03-07 | 2024-03-11 | $90.69 | $794K | +1.0% | +1.5% | +16.7% |
| BPMC | SELL | 2023-10-04 | 2023-10-05 | $48.06 | $362K | +3.6% | +20.0% | +81.4% |
| BPMC | SELL | 2023-03-06 | 2023-03-08 | $45.70 | $175K | +3.2% | -3.4% | +32.1% |
| BPMC | SELL | 2022-10-04 | 2022-10-05 | $67.30 | $468K | -16.5% | -34.8% | -32.8% |
| BPMC | SELL | 2022-03-07 | 2022-03-08 | $56.19 | $118K | +17.5% | +23.4% | +4.6% |
| BPMC | SELL | 2021-10-05 | 2021-10-07 | $98.18 | $636K | +4.3% | +15.4% | -5.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.